Business description: Syneos Health, Inc.

Syneos Health, Inc. is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services. The Company operates through two business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The Clinical Solutions segment offers individual services including product development, project management, protocol development, investigational site recruitment, and clinical monitoring. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions (public relations, advertising, and medical communications), and consulting services. The Company's customers include small, mid-sized, and large companies in the biopharmaceutical, biotechnology, and medical device industries.

Number of employees: 28,768

Sales by Activity: Syneos Health, Inc.

Fiscal Period: December 2019 (USD) 2020 (USD) 2021 (USD) 2022 (USD)

Clinical Solutions

3.42B 3.31B 4.01B 4.07B

Commercial Solutions

1.25B 1.11B 1.2B 1.32B

Geographical breakdown of sales: Syneos Health, Inc.

Fiscal Period: December 2019 (USD) 2020 (USD) 2021 (USD) 2022 (USD)

United States

2.93B 2.64B 2.95B 3.03B

Europe, Middle East, and Africa

1.06B 1.06B 1.33B 1.33B

Asia-Pacific

445M 465M 594M 680M

North America (Excluding U.S.)

150M 152M 194M 201M

Latin America

96.38M 99.1M 141M 152M

Executive Committee: Syneos Health, Inc.

Manager TitleAgeSince
Chief Executive Officer 52 2024-09-30
Director of Finance/CFO 57 2023-06-30
Chief Operating Officer 52 2022-04-28
Chief Tech/Sci/R&D Officer - 2022-04-18
Chief Tech/Sci/R&D Officer - 2020-11-16

Composition of the Board of Directors: Syneos Health, Inc.

Director TitleAgeSince
Director/Board Member 54 2023-09-27
Chairman 67 2024-10-08
Director/Board Member - 2023-09-27
Director/Board Member - 2023-09-27
Director/Board Member 43 2023-09-27
Director/Board Member 59 2022-04-28
Director/Board Member 36 -
Director/Board Member - 2023-09-27
Director/Board Member - 2023-09-27

Company details: Syneos Health, Inc.

Syneos Health, Inc.

1030 Sync Street

27560-5468, Morrisville

+

http://www.syneoshealth.com
address Syneos Health, Inc.(SYNH)

Other Biotechnology & Medical Research

Change 5d. change 1-year change 3-years change Capi.($)
-1.18%-2.96%-13.53%-15.84% 42.68B
-4.15%-5.24%+271.22%+477.96% 31.73B
-1.84%+0.68%+24.48%-10.08% 30.62B
-3.51%-6.19%+5.10%+21.75% 30.03B
-2.89%-6.70%+14.76%+14.13% 24.25B
-3.83%-6.10% - - 13.07B
-0.18%+3.94%+13.97%+7.09% 13.17B
-0.97%+1.60%+54.73%+109.79% 12.97B
-0.87%-2.64%+111.35%+76.24% 12.31B
Average -2.16%-2.62%+60.26%+85.13% 23.42B
Weighted average by Cap. -2.32%-3.13%+58.42%+89.16%
  1. Stock Market
  2. Equities
  3. SYNH Stock
  4. Company Syneos Health, Inc.